Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 14, 2026
Reporting period
Not applicable
Filed with the SEC
May 18, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001276038-26-000002
Filed / recorded
May 18, 2026, 8:15 PM UTC
Added to OQRO
Oct 6, 2026, 10:35 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
COLLEGIUM PHARMACEUTICAL, INC
Issuer CIK
1267565
Ticker
COLL
Reporting person
Gino Santini
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
May 14, 2026
Transaction code
A
Shares / units
8,741
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
103,783
Ownership form
Direct
Amendment
No
Footnotes from the filing
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on the earlier of May 14, 2027, or the date of the Issuer's 2027 Annual Meeting of Shareholders, subject to the director's continued service with the Issuer. The RSUs will be settled on such date, or, upon the election of the director, on the earlier of the end of the director's service on the Board of Directors, the director's death or disability, or a change in control of the Issuer, in shares of the Issuer's common stock.